Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Diphenhydramine Dosing for Prevention of Prochlorperazine-Induced Akathisia in Children

Dosing Guidelines

  • The recommended dose of diphenhydramine for preventing akathisia in children treated with prochlorperazine is 1-2 mg/kg per dose (maximum 50 mg) administered parenterally 1, 2, 3
  • Diphenhydramine should be administered at 1-2 mg/kg per dose with a maximum single dose of 50 mg 1, 2
  • The parenteral route (intravenous or intramuscular) is preferred for acute prevention when prochlorperazine is given intravenously 4

Clinical Considerations

  • The onset of action for intravenous diphenhydramine is several minutes, with effects lasting up to 4-6 hours 4

Pitfalls and Caveats

  • Diphenhydramine may cause excessive sedation when combined with prochlorperazine, requiring careful monitoring of respiratory status and level of consciousness 4
  • Other potential adverse effects of diphenhydramine include hypotension, dizziness, blurred vision, dry mouth, epigastric discomfort, and urinary retention 4
  • For children with a history of adverse reactions to antihistamines, alternative approaches to managing akathisia risk should be considered 5

Alternative Approaches

  • For children with severe nausea requiring antiemetic therapy but at high risk for akathisia, alternative antiemetics such as ondansetron may be considered 6